<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-10-05T21:03:03.136Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-10-05T21:03:03.136Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-10-05T21:03:03.136Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-10-05T21:03:03.136Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-10-05T21:03:03.136Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1791234032007</loc>
    <lastmod>2026-10-05T21:00:32.007Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;OpenAI in Talks With UAE Funds, BlackRock for $30 Billion Round&amp;#39;- Bloomberg</image:title>
      <image:caption>OpenAI is in discussions with UAE investment funds and BlackRock to secure a $30 billion funding round. This potential investment could significantly enhance OpenAI&#39;s financial position and growth prospects. The talks indicate strong interest from major financial players in the AI sector.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DINO:1791233722791</loc>
    <lastmod>2026-10-05T20:55:22.791Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DINO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on HF Sinclair, Raises Price Target to $133</image:title>
      <image:caption>UBS analyst Manav Gupta has reiterated a Buy rating on HF Sinclair (NYSE: DINO) and increased the price target from $126 to $133. This adjustment reflects positive expectations for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MCRP:1791233461735</loc>
    <lastmod>2026-10-05T20:51:01.735Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MCRP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Micropolis AI Robotics Obtains NYSE Noncompliance Notice</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/WQEY:1791233368341</loc>
    <lastmod>2026-10-05T20:49:28.341Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/WQEY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>WISeQey Starts Trading On Nasdaq And SIX As WQEY</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TSLA:1791233364924</loc>
    <lastmod>2026-10-05T20:49:24.924Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/05/Indianapolis---February-28--2025-Tesla-E.jpg?width=250&amp;height=187</image:loc>
      <image:title>Tesla&amp;#39;s Q3 Delivery Beat Is Just the Start: Gene Munster Says TSLA Will ‘Crush Traditional Automakers’</image:title>
      <image:caption>Tesla Inc (NASDAQ: TSLA) recently reported third quarter delivery figures that exceeded analyst expectations, contributing to a rise in its stock price. Market expert Gene Munster predicts that Tesla will significantly outperform traditional automakers like Ford and General Motors, which saw a 75% decline in electric vehicle deliveries in September. Munster estimates that Tesla&#39;s deliveries could increase by around 15% next year, driven by rising gas prices and the appeal of its Full Self-Driving (FSD) software, despite a 2% year-over-year decline in September deliveries due to the expiration of the federal EV tax credit.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OI:1791233098426</loc>
    <lastmod>2026-10-05T20:44:58.426Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Downgrades O-I Glass to Neutral, Lowers Price Target to $6</image:title>
      <image:caption>UBS analyst Joshua Spector has downgraded O-I Glass (NYSE: OI) from a Buy rating to Neutral. The price target for the stock has been reduced from $11 to $6.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VTRS:1791233013524</loc>
    <lastmod>2026-10-05T20:43:33.524Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VTRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Viatris, Raises Price Target to $26</image:title>
      <image:caption>UBS analyst Ashwani Verma has maintained a &#39;Buy&#39; rating on Viatris (NASDAQ: VTRS) and increased the price target from $23 to $26. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AREC:1791232786971</loc>
    <lastmod>2026-10-05T20:39:46.971Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AREC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>American Resources  Enters Asset Purchase Agreement With Wyoming County Coal On Sept 29, 2026; Purchase Price For Bought Assets Is $40M; Bought Property Includes Rights To Elements And Minerals In Refuse Piles</image:title>
      <image:caption>American Resources Corporation (ticker: AREC) has entered into an asset purchase agreement with Wyoming County Coal on September 29, 2026, for a total purchase price of $40 million. The acquired property includes rights to elements and minerals found in refuse piles.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AREC:1791232772538</loc>
    <lastmod>2026-10-05T20:39:32.538Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AREC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>American Resources Inks Asset Purchase Agreement With Wyoming County Coal On Sept. 29 For $40M; Bought Property Includes Rights To Elements And Minerals In Refuse Piles</image:title>
      <image:caption>American Resources Corporation (AREC) has entered into an asset purchase agreement with Wyoming County Coal for $40 million, finalized on September 29. The acquisition includes rights to elements and minerals located in refuse piles associated with the property. This strategic move is aimed at enhancing the company&#39;s resource portfolio.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/YFOR:1791232689505</loc>
    <lastmod>2026-10-05T20:38:09.505Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/YFOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>YYForce shares are trading lower after the company announced a $20 million offering.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KLD:1791232649826</loc>
    <lastmod>2026-10-05T20:37:29.826Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KLD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Franco-Nevada Acquires Aggregate Of 10M Common Shares Of Kenorland Minerals, Representing ~12.42% Of Outstanding Common Shares</image:title>
      <image:caption>Franco-Nevada Corporation has acquired 10 million common shares of Kenorland Minerals, representing approximately 12.42% of the company&#39;s outstanding shares, for a total purchase price of $22.2 million at $2.22 per share. The shares were acquired from John Tognetti and Zach Flood, with Tognetti&#39;s stake in Kenorland reduced to about 3.93% following the transaction. Franco-Nevada did not previously own any shares of Kenorland and has no current plans to acquire more, although future acquisitions may depend on market conditions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NVAX:1791232341917</loc>
    <lastmod>2026-10-05T20:32:21.917Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/05/Novavax-Vaccine.jpg?width=250&amp;height=187</image:loc>
      <image:title>Novavax Shorts on Edge as Russia Plague Fears Spread</image:title>
      <image:caption>Novavax Inc. (NASDAQ: NVAX) shares surged over 20% to $12.56 amid fears of a suspected plague case in Russia, with the stock nearing its 52-week high of $13.04. The company is one of the most heavily shorted stocks, with short sellers holding approximately 30.43% of its float. The surge in stock price reflects a classic short squeeze scenario, as the volume on Monday accounted for about 40% of the short position. The situation remains fluid, pending test results from the affected region.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ECL:1791232229285</loc>
    <lastmod>2026-10-05T20:30:29.285Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ECL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Ecolab, Raises Price Target to $344</image:title>
      <image:caption>UBS analyst Joshua Spector has maintained a Buy rating on Ecolab (NYSE: ECL) and raised the price target from $342 to $344. This adjustment reflects continued confidence in the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PCVX:1791232151519</loc>
    <lastmod>2026-10-05T20:29:11.519Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PCVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vaxcyte Announces $500M Equity Offering And $500M Convertible Notes Offering</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PFSI:1791231842501</loc>
    <lastmod>2026-10-05T20:24:02.501Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PFSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PennyMac Financial Services Completes Deployment Of VantageScore 4.0 Across Its Entire Production Platform</image:title>
      <image:caption>PennyMac Financial Services, Inc. (NYSE: PFSI) has completed the deployment of VantageScore 4.0 across its entire production platform, which includes consumer direct, broker direct, and correspondent channels. This move is part of the company&#39;s ongoing investment in next-generation lending technology aimed at reducing costs and increasing access to homeownership. The deployment aligns with recent announcements from the Federal Housing Finance Agency and the Department of Housing and Urban Development that have introduced credit score competition in the mortgage market for the first time in decades.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HTB:1791231753273</loc>
    <lastmod>2026-10-05T20:22:33.273Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HTB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>HomeTrust Bancshares Board Authorizes Repurchase Of Up To Additional 790K Shares</image:title>
      <image:caption>HomeTrust Bancshares, Inc. (NYSE: HTB) has completed its 5% stock repurchase program, buying back 832,000 shares at an average price of $47.70 per share. The Board of Directors has now authorized the repurchase of an additional 790,000 shares, which represents about 5% of the company&#39;s outstanding shares. These shares may be acquired through open market purchases or privately negotiated transactions, depending on market conditions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GLW:1791231715462</loc>
    <lastmod>2026-10-05T20:21:55.462Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GLW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Corning, Raises Price Target to $201</image:title>
      <image:caption>UBS analyst Joshua Spector has maintained a Buy rating on Corning (NYSE: GLW) and increased the price target from $196 to $201. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ESI:1791231649253</loc>
    <lastmod>2026-10-05T20:20:49.253Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ESI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Element Solutions, Raises Price Target to $48</image:title>
      <image:caption>UBS analyst Joshua Spector has maintained a &#39;Buy&#39; rating on Element Solutions (NYSE: ESI) and increased the price target from $47 to $48. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SKY:1791231518431</loc>
    <lastmod>2026-10-05T20:18:38.431Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SKY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Champion Homes Agrees To Acquire Assets Of Timberline Homes; Financial Terms Not Disclosed</image:title>
      <image:caption>Champion Homes, Inc. (NYSE: SKY) has announced a definitive agreement to acquire the assets of Timberline Homes, Inc., which includes nine retail locations in key Southeastern U.S. markets such as Alabama, Mississippi, and Florida. The acquisition is expected to enhance Champion&#39;s manufacturing and distribution capabilities in the region. Financial terms of the deal have not been disclosed.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OVID:1791231405918</loc>
    <lastmod>2026-10-05T20:16:45.918Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OVID/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Initiates Coverage On Ovid Therapeutics with Buy Rating, Announces Price Target of $7</image:title>
      <image:caption>Guggenheim analyst Delma Caiati has initiated coverage on Ovid Therapeutics (NASDAQ: OVID) with a Buy rating. The firm has set a price target of $7 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ABBV:1791231268176</loc>
    <lastmod>2026-10-05T20:14:28.176Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AbbVie Lowers FY2026 Adjusted EPS Guidance To $13.76-$13.96/Share, Q3 To $3.73-$3.77/Share, On $216M Acquired R&amp;amp;D And Milestone Expense</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VIR:1791231147589</loc>
    <lastmod>2026-10-05T20:12:27.589Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VIR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Vir Biotechnology To Reveal Expanded Phase 2 SOLSTICE Results for Elebsiran And Tobevibart In Hepatitis Delta at AASLD’s The Liver Meeting 2026</image:title>
      <image:caption>Vir Biotechnology, Inc. (NASDAQ: VIR) will present expanded results from its Phase 2 SOLSTICE trial, which evaluates the combination of elebsiran and tobevibart for chronic hepatitis delta. This presentation is scheduled for the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2026, taking place in Denver, CO from November 5-9, 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AVNW:1791231133189</loc>
    <lastmod>2026-10-05T20:12:13.189Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVNW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Aviat Networks Announces License-To-Manufacture Agreement With Dixon Electro Appliances For Designated Products In Aviat&amp;#39;s WTM 4000 Family In India</image:title>
      <image:caption>Aviat Networks, Inc. has entered into a license-to-manufacture agreement with Dixon Electro Appliances for products in its WTM 4000 family in India. This agreement allows Dixon to manufacture and sell approved products to select Indian telecommunications operators, while Aviat retains its intellectual property and continues to provide software and services. This strategic move aims to enhance Aviat&#39;s presence in India&#39;s growing microwave market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NEO:1791231113561</loc>
    <lastmod>2026-10-05T20:11:53.561Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NeoGenomics Sees Q3 Revenue Of About $209M; Reiterates FY2026 Revenue, Adjusted EBITDA Guidance, Expects To Raise Revenue Guidance Midpoint On Q3 Call</image:title>
      <image:caption>NeoGenomics reported approximately $209 million in revenue for Q3. The company reiterated its revenue and adjusted EBITDA guidance for FY2026 and indicated that it expects to raise the revenue guidance midpoint during the Q3 earnings call.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ADEA:1791231079275</loc>
    <lastmod>2026-10-05T20:11:19.275Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ADEA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Adeia Enters Multi-Year Renewal Of IP License Agreement With Spectrum</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/LCID:1791231068576</loc>
    <lastmod>2026-10-05T20:11:08.576Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LCID/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lucid Produced 2,954 Vehicles And Delivered 3,806 Vehicles During Q3 2026</image:title>
      <image:caption>Lucid Group, Inc. produced 2,954 vehicles and delivered 3,806 vehicles in Q3 2026, with deliveries surpassing production as part of an inventory reduction strategy. The company aims for $1.4 billion in cash flow improvements this year, aligning production with near-term demand. The production decline follows the elimination of a second shift at AMP-1 in June, while demand for the Lucid Gravity is reportedly increasing.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EQ:1791231031003</loc>
    <lastmod>2026-10-05T20:10:31.003Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Australia&amp;#39;s Therapeutic Goods Administration Grants Equillium Human Research Ethics Committee Approval For Phase 1 Clinical Trial Of EQ504.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KRRO:1791231025884</loc>
    <lastmod>2026-10-05T20:10:25.884Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KRRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Korro Bio Doses First First Group Of Patients In Its Phase 1/2 Clinical Study Of KRRO-121 To Treat Hyperammonemia In Patients With Urea Cycle Disorders</image:title>
      <image:caption>Korro Bio, Inc. (Nasdaq: KRRO) has announced that it has dosed the first cohort of participants in its Phase 1/2 clinical trial for KRRO-121, an RNA-editing oligonucleotide aimed at treating hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy. This development marks a significant step in the company&#39;s efforts to leverage its OPERA® platform for genetic medicines targeting rare diseases.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BTCUSD:1791231020988</loc>
    <lastmod>2026-10-05T20:10:20.988Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/05/Crypto-Regulation-Is-Shown-On-The-Busine.jpg?width=250&amp;height=187</image:loc>
      <image:title>CLARITY Act Failure Spurs New CFTC Crypto Rules, Chairman Selig Says It&amp;#39;s &amp;#39;Just The Beginning&amp;#39;</image:title>
      <image:caption>The Commodity Futures Trading Commission (CFTC) is advancing its own crypto market-structure rules following the failure of the CLARITY Act in Congress. Chairman Michael Selig announced proposals for Regulation Crypto Asset Transactions (Regulation CTX) and Regulation Crypto Asset Markets (Regulation CAM), which would establish a federal framework for exchanges trading assets like Bitcoin and Ethereum. These regulations aim to provide oversight for leveraged crypto trading, enhance market integrity, and protect customer funds, marking a shift from previous enforcement-focused approaches. Selig indicated that this initiative is just the beginning of further regulatory developments in the crypto space.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BWXT:1791230901822</loc>
    <lastmod>2026-10-05T20:08:21.822Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BWXT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BWX Technologies Says Prodigy Clean Energy And First Nations Selected BANR Microreactor For New Brunswick Nuclear Plant, Pending Definitive Agreement</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AVNW:1791230876432</loc>
    <lastmod>2026-10-05T20:07:56.432Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AVNW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Aviat Networks Inks Manufacture Agreement With Dixon Electro Appliance Private For Select Products In Aviat&amp;#39;s WTM 400 Portfolio In India</image:title>
      <image:caption>Aviat Networks, Inc. (NASDAQ: AVNW) has entered into a license-to-manufacture agreement with Dixon Electro Appliances Private Ltd. for select products in its WTM 4000 portfolio in India. Dixon will manufacture and sell these products to specific Indian telecommunications operators, while Aviat retains its intellectual property and will continue to provide software and services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MAT:1791230861974</loc>
    <lastmod>2026-10-05T20:07:41.974Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;Barbie-Maker Mattel Faces Growing Shareholder Pressure to Consider a Sale; Ariel Investments, Which Has A 5.4% Stake In The Toy Maker, Said It Believes The Company’s Shares Remain Significantly Undervalued&amp;#39;- WSJ</image:title>
      <image:caption>Mattel, the maker of Barbie, is facing increasing pressure from shareholders, particularly Ariel Investments, which holds a 5.4% stake in the company. Ariel believes that Mattel&#39;s shares are significantly undervalued and is urging the company to consider a sale. This situation highlights the growing concerns among investors regarding the company&#39;s current market valuation.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OPCH:1791230839432</loc>
    <lastmod>2026-10-05T20:07:19.432Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OPCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Option Care Health shares are trading higher following reports suggesting McKesson and Clayton Dubilier &amp;amp; Rice are nearing a deal to acquire the company.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TROX:1791230808379</loc>
    <lastmod>2026-10-05T20:06:48.379Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TROX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Neutral on Tronox Holdings, Lowers Price Target to $4.5</image:title>
      <image:caption>UBS analyst Joshua Spector has maintained a Neutral rating on Tronox Holdings (NYSE: TROX) while lowering the price target from $7 to $4.5. This adjustment reflects a revised outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DRS:1791230671932</loc>
    <lastmod>2026-10-05T20:04:31.932Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Leonardo DRS Completes Final Training And Delivery For Improved Night/Day Observation Device Block III Thermal Weapon Sights Provided To Australian Army Under LAND 159 Tranche 1 Program</image:title>
      <image:caption>Leonardo DRS, Inc. has completed the final training and delivery of the Improved Night/Day Observation Device (INOD) Block III thermal weapon sights to the Australian Army as part of the LAND 159 Tranche 1 program. The INOD Block III is designed for use by snipers and special operations forces to enhance target detection in low-light and adverse conditions, maintaining compatibility with existing optics and magnifications from 5x to over 25x.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OPCH:1791230625997</loc>
    <lastmod>2026-10-05T20:03:45.997Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OPCH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>&amp;#39;McKesson and CD&amp;amp;R near $5B-plus deal to buy infusion services provider&amp;#39;- Financial Times</image:title>
      <image:caption>McKesson Corporation is nearing a deal valued at over $5 billion to acquire an infusion services provider in partnership with Clayton, Dubilier &amp; Rice (CD&amp;R). This strategic move is aimed at expanding McKesson&#39;s capabilities in the healthcare services sector. The acquisition is expected to enhance McKesson&#39;s service offerings and strengthen its market position.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ORIC:1791230557552</loc>
    <lastmod>2026-10-05T20:02:37.552Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ORIC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>ORIC Pharmaceuticals Announces Agreement With Cancer Research UK To Advance Potential CIP2A-Targeted Therapy Into Clinical Development</image:title>
      <image:caption>ORIC Pharmaceuticals has entered into an agreement with Cancer Research UK to advance ORIC-259, a potential first-in-class small molecule mRNA degrader targeting the previously undruggable target CIP2A, into clinical development. Cancer Research UK will fully fund and execute the CTA-enabling studies and Phase 1/2 clinical trials. ORIC retains the exclusive option to reacquire rights to ORIC-259 after the Phase 1/2 data is available, while Cancer Research UK may receive milestone payments and royalties.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GRAL:1791230547108</loc>
    <lastmod>2026-10-05T20:02:27.108Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GRAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GRAIL To Present New NHS-Galleri Trial Data At Early Detection Of Cancer Conference And ESMO Congress</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MEOH:1791230525043</loc>
    <lastmod>2026-10-05T20:02:05.043Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MEOH/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Maintains Buy on Methanex, Raises Price Target to $74</image:title>
      <image:caption>UBS analyst Joshua Spector has maintained a Buy rating on Methanex (NASDAQ: MEOH) and increased the price target from $71 to $74. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ZETA:1791230472268</loc>
    <lastmod>2026-10-05T20:01:12.268Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ZETA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Zeta Global Agrees To Acquire AI Engineering Firm Senso; Financial Terms Not Disclosed</image:title>
      <image:caption>Zeta Global (NYSE: ZETA) has announced a definitive agreement to acquire Senso, an AI engineering firm backed by Y Combinator. The financial terms of the acquisition have not been disclosed. This move aims to enhance Zeta&#39;s Generative Engine Optimization (GEO) offering by bringing additional technology in-house and increasing AI engineering talent.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NVDA:1791230191600</loc>
    <lastmod>2026-10-05T19:56:31.600Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Shares of software companies are trading higher amid falling oil prices and a broader tech rally, as Nvidia reaches a new all-time high and investors anticipate a $6 trillion valuation by the end of the month.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/XP:1791230184274</loc>
    <lastmod>2026-10-05T19:56:24.274Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/05/Benzinga-Quick-Spark.jpg?width=250&amp;height=187</image:loc>
      <image:title>QUICK SPARK: Brazil&amp;#39;s Retail Broker XP Notches Best Day Ever, Tops Russell 1000 Performers</image:title>
      <image:caption>XP Inc. (NASDAQ: XP) experienced a significant stock surge, rising 32.8% to $28.25, marking its best trading day in Wall Street history and leading the Russell 1000 performers. This increase surpasses its previous record of a 26.4% rally in March 2020 and brings the stock to its highest level since April 2022. Year-to-date, XP shares have increased by 76%, driven by investor sentiment favoring fiscal conservatism following Brazil&#39;s recent elections.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/USO:1791230161725</loc>
    <lastmod>2026-10-05T19:56:01.725Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Oil is trading lower following reports suggesting that Middle East oil exports have risen above pre-war level.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DHR:1791229594119</loc>
    <lastmod>2026-10-05T19:46:34.119Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Danaher shares are trading higher after RBC Capital raised its price target on the stock from $215 to $250.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NTRA:1791229545358</loc>
    <lastmod>2026-10-05T19:45:45.358Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Natera shares are trading higher after the company and Alliance Foundation Trials announced the launch of AFT-70 NAVIGATE, a phase III trial evaluating an MRD-guided treatment strategy for early breast cancer.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NBIS:1791229419162</loc>
    <lastmod>2026-10-05T19:43:39.162Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NBIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Nebius Group shares are trading lower after Form 4 filings showed several executives have sold the company shares.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ABT:1791229252959</loc>
    <lastmod>2026-10-05T19:40:52.959Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Abbott shares are trading higher after the company received FDA approval for CardioMEMS HF System updates that add new patient-facing features through the CardioGuide HF App.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MET:1791229126824</loc>
    <lastmod>2026-10-05T19:38:46.824Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MET/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MetLife shares are trading higher after TD Cowen raised its price target on the stock from $105 to $110.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/STT:1791228946914</loc>
    <lastmod>2026-10-05T19:35:46.914Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citigroup Maintains Buy on State Street, Raises Price Target to $212</image:title>
      <image:caption>Citigroup analyst Benjamin Gerlinger has maintained a Buy rating on State Street (NYSE: STT) and raised the price target from $210 to $212.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CART:1791228880854</loc>
    <lastmod>2026-10-05T19:34:40.854Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CART/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maplebear shares are trading higher after Wells Fargo raised its price target on the stock from $54 to $56.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
</urlset>